Pfizer's maternal RSV vaccine, Abrysvo, is also available as a preventive measure for young infants. It is advised to be given to women 32 to 36 weeks into a pregnancy to prevent lower respiratory tract infection and severe disease in infants until they are six months old.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/tur97mf
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment